Breast
Biomarkers
Cervical
Colorectal
Diffuse B Cell Lymphoma
Endometrial
Follicular Lymphoma
GIST
Head & Neck
Leukemia
Liver
Lung
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Myelofibrosis
NSCLC
Ovarian
Pancreatic
Pediatric
Prostate
All
Blog
Cancer
Glossary
Guides
Infographics
Magazine
News
Newsletter
Quizzes
Video
Webinar
The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. The impact of the pandemic on European health systems and more broadly on society, will make it necessary for sponsors to adjust how they manage clinical trials and the people who participate in these trials. It is an extensive guidance to sponsors in response to coronavirus pandemic.
Most Popular
Get a Free Consultation
Our specialized team will contact you within 24 hours.
2 Comments
Are there any clinical trials that stage 3 cancer patient how had Covid can join? Our friend is lung cancer and did well with corona virus.
Hello Susan, Thank you for reaching out. Our Artificial Intelligence database will search through thousands of clinical trials to match patients to the best/most appropriate ones that they appear to be eligible for based off of their medical records, this will include reviewing past medical history, in this case would be Covid-19. We would be happy to assist your friend in finding clinical trials she may be eligible for, we are available by live chat, email at support@massivebio.com, and by phone at 844-627-7246.